Selected article for: "cross immunity and long term immunity"

Author: Scourfield, D Oliver; Reed, Sophie G; Quastel, Max; Alderson, Jennifer; Bart, Valentina M T; Teijeira Crespo, Alicia; Jones, Ruth; Pring, Ellie; Richter, Felix Clemens; Burnell, Stephanie E A
Title: The role and uses of antibodies in COVID-19 infections: a living review
  • Cord-id: qg09f8jw
  • Document date: 2021_1_28
  • ID: qg09f8jw
    Snippet: Coronavirus disease 2019 has generated a rapidly evolving field of research, with the global scientific community striving for solutions to the current pandemic. Characterizing humoral responses towards SARS-CoV-2, as well as closely related strains, will help determine whether antibodies are central to infection control, and aid the design of therapeutics and vaccine candidates. This review outlines the major aspects of SARS-CoV-2-specific antibody research to date, with a focus on the various
    Document: Coronavirus disease 2019 has generated a rapidly evolving field of research, with the global scientific community striving for solutions to the current pandemic. Characterizing humoral responses towards SARS-CoV-2, as well as closely related strains, will help determine whether antibodies are central to infection control, and aid the design of therapeutics and vaccine candidates. This review outlines the major aspects of SARS-CoV-2-specific antibody research to date, with a focus on the various prophylactic and therapeutic uses of antibodies to alleviate disease in addition to the potential of cross-reactive therapies and the implications of long-term immunity.

    Search related documents:
    Co phrase search for related documents
    • adaptive immune response and live virus: 1, 2, 3
    • adaptive immune response and long study: 1
    • adaptive immune response and long term immunity: 1, 2
    • adaptive immune response and long term protection: 1, 2, 3
    • adaptive immune response and long term protection role: 1, 2
    • adaptive immune response and long term study: 1
    • adaptive immune response and mabs monoclonal antibody: 1
    • ade antibody dependent enhancement and live virus: 1, 2, 3
    • ade antibody dependent enhancement and long term protection: 1
    • ade antibody dependent enhancement and mab treatment: 1, 2
    • ade antibody dependent enhancement and mabs monoclonal antibody: 1